Segment Disclosures - Schedule of Information for the Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Segment Reporting, Revenue [Abstract]
Total revenues	$ 771,579	$ 694,348	$ 1,524,531	$ 1,397,237
Depreciation and amortization	(283,390)	(265,916)	(573,124)	(534,462)
General and administrative	(22,517)	(20,764)	(47,108)	(46,882)
Transaction costs	(9,172)	(10,215)	(33,321)	(15,749)
Gain (loss) on sales of real estate, net	9,988	1,636	60,657	1,636
Gain (loss) on debt extinguishments	0	0	(403)	0
Other income (expense), net	16,766	(4,692)	156,545	(10,818)
Income tax benefit (expense)	1,402	(2,382)	1,148	(4,462)
Equity income (loss) from unconsolidated joint ventures	2,509	1,747	6,774	(400)
Net income (loss)	63,241	39,019	262,897	89,083
Interest income and other	21,769	15,806	35,940	31,627
Interest expense	(92,280)	(75,063)	(179,572)	(147,756)
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	59,330	39,654	254,975	93,945
Operating Segment
Segment Reporting, Revenue [Abstract]
Total revenues	743,238	672,835	1,474,612	1,353,812
Adjusted NOI - outpatient medical and lab	340,619	341,639	680,015	685,214
Depreciation and amortization	(226,917)	(234,725)	(465,253)	(470,472)
General and administrative	(18,711)	(18,382)	(40,016)	(41,368)
Transaction costs	(4,894)	(10,215)	(10,533)	(15,749)
Gain (loss) on sales of real estate, net	6,104		56,773	1,636
Gain (loss) upon change of control, net			46,270
Other income (expense), net	301	55	92,994	514
Income tax benefit (expense)	(1,746)	1,607	(624)	3,201
Equity income (loss) from unconsolidated joint ventures		(1,009)	(111)	(2,460)
Plus: Adjustments to NOI	20,569	23,234	40,132	49,985
Other non-reportable revenues	6,572	5,707	13,979	11,798
Interest income and other	21,769	15,806	35,940	31,627
Other non-reportable operating expenses	(3,340)	(2,896)	(7,457)	(5,851)
Interest expense	(91,930)	(74,114)	(178,871)	(145,859)
Impairments and loan loss reserves, net	1,479	(3,499)	3,754	63
Less: Healthpeak’s share of unconsolidated joint venture NOI	(11,847)	(9,948)	(22,672)	(15,347)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI	6,444	7,219	14,193	14,413
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	59,330	39,654	254,975	93,945
Operating Segment \| Outpatient medical
Segment Reporting, Revenue [Abstract]
Total revenues	310,670	314,775	628,887	629,232
Operating expenses	(103,476)	(102,435)	(209,740)	(204,706)
Healthpeak’s share of unconsolidated joint venture NOI	5,837	4,488	10,425	8,753
Noncontrolling interests’ share of consolidated joint venture NOI	(6,444)	(7,219)	(14,139)	(14,413)
NOI - outpatient medical and lab	206,587	209,609	415,433	418,866
Adjustments to NOI	(8,582)	(10,746)	(19,051)	(22,660)
Adjusted NOI - outpatient medical and lab	198,005	198,863	396,382	396,206
Compensation and property management	(15,487)	(14,595)	(31,229)	(28,858)
Repairs and maintenance	(18,725)	(14,700)	(37,032)	(29,586)
Other segment items	(27,262)	(30,367)	(55,834)	(62,458)
Operating Segment \| Lab
Segment Reporting, Revenue [Abstract]
Total revenues	216,112	209,205	428,924	426,798
Operating expenses	(67,521)	(59,401)	(136,403)	(117,059)
Healthpeak’s share of unconsolidated joint venture NOI	6,010	5,460	12,247	6,594
Noncontrolling interests’ share of consolidated joint venture NOI	0	0	(54)	0
NOI - outpatient medical and lab	154,601	155,264	304,714	316,333
Adjustments to NOI	(11,987)	(12,488)	(21,081)	(27,325)
Adjusted NOI - outpatient medical and lab	142,614	142,776	283,633	289,008
Compensation and property management	(9,433)	(8,277)	(18,590)	(16,587)
Repairs and maintenance	(10,405)	(8,202)	(19,333)	(15,560)
Other segment items	(13,334)	(13,246)	(28,901)	(25,792)
Operating Segment \| Senior housing
Segment Reporting, Revenue [Abstract]
Total revenues	216,456	148,855	416,801	297,782
Compensation and property management	(100,605)	(71,745)	(191,613)	(141,748)
Food	(9,870)	(6,782)	(18,568)	(13,225)
Real estate taxes	(6,566)	(4,324)	(13,046)	(8,832)
Repairs and maintenance	(7,719)	(4,873)	(14,371)	(9,719)
Utilities	(8,701)	(5,719)	(16,846)	(11,382)
Other segment items	(25,325)	(18,006)	(48,940)	(36,802)
Depreciation and amortization	(56,473)	(31,191)	(107,871)	(63,990)
Interest expense	(350)	(949)	(701)	(1,897)
Transaction costs	(4,278)		(22,788)
Gain (loss) on sales of real estate, net	3,884		3,884
Gain (loss) on debt extinguishments			(403)
Other income (expense), net	16,465	(4,747)	17,281	(11,332)
Income tax benefit (expense)	1,746	(1,607)	624	(3,201)
Equity income (loss) from unconsolidated joint ventures		1,009	111	2,460
Net income (loss)	14,858	(2,461)	42,732	(7,400)
Operating Segment \| Senior housing \| Nonrelated Party
Segment Reporting, Revenue [Abstract]
General and administrative	(1,334)	$ (2,382)	(4,292)	$ (5,514)
Operating Segment \| Senior housing \| Related Party Management Fee
Segment Reporting, Revenue [Abstract]
General and administrative	$ (2,472)		$ (2,800)

Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI.

No definition available.